| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,858 |
22,353 |
$2.61M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,025 |
18,617 |
$1.96M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19,331 |
18,847 |
$1.80M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16,444 |
16,046 |
$1.76M |
| S9083 |
Global fee urgent care centers |
9,267 |
8,603 |
$712K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
11,938 |
11,365 |
$99K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20,105 |
9,643 |
$62K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,506 |
9,122 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
568 |
510 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
42 |
40 |
$3K |
| 99000 |
|
2,342 |
2,236 |
$3K |
| 87807 |
|
999 |
978 |
$3K |
| 81003 |
|
1,505 |
1,420 |
$2K |
| S8301 |
Infection control supplies, not otherwise specified |
558 |
537 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
162 |
153 |
$914.00 |
| 71046 |
Radiologic examination, chest; 2 views |
87 |
87 |
$875.98 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
215 |
215 |
$686.79 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
242 |
221 |
$169.96 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
12 |
$11.89 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$11.83 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
1,374 |
1,350 |
$0.00 |
| 99051 |
|
12 |
12 |
$0.00 |
| 99072 |
|
233 |
207 |
$0.00 |
| 87634 |
|
12 |
12 |
$0.00 |
| 81025 |
|
135 |
128 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$0.00 |
| A9150 |
Non-prescription drugs |
12 |
12 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
49 |
49 |
$0.00 |